Pyrogallol protects against influenza A virus-triggered lethal lung injury by activating the Nrf2–PPAR-γ–HO-1 signaling axis

Abstract

Pyrogallol, a natural polyphenol compound (1,2,3-trihydroxybenzene), has shown efficacy in the therapeutic treatment of disorders associated with inflammation. Nevertheless, the mechanisms underlying the protective properties of pyrogallol against influenza A virus infection are not yet established. We established in this study that pyrogallol effectively alleviated H1N1 influenza A virus-induced lung injury and reduced mortality. Treatment with pyrogallol was found to promote the expression and nuclear translocation of nuclear factor erythroid-2-related factor 2 (Nrf2) and peroxisome proliferator-activated receptor gamma (PPAR-γ). Notably, the activation of Nrf2 by pyrogallol was involved in elevating the expression of PPAR-γ, both of which act synergistically to enhance heme oxygenase-1 (HO-1) synthesis. Blocking HO-1 by zinc protoporphyrin (ZnPP) reduced the suppressive impact of pyrogallol on H1N1 virus-mediated aberrant retinoic acid-inducible gene-I-nuclear factor kappa B (RIG-I–NF-κB) signaling, which thus abolished the dampening effects of pyrogallol on excessive proinflammatory mediators and cell death (including apoptosis, necrosis, and ferroptosis). Furthermore, the HO-1-independent inactivation of janus kinase 1/signal transducers and activators of transcription (JAK1/STATs) and the HO-1-dependent RIG-I-augmented STAT1/2 activation were both abrogated by pyrogallol, resulting in suppression of the enhanced transcriptional activity of interferon-stimulated gene factor 3 (ISGF3) complexes, thus prominently inhibiting the amplification of the H1N1 virus-induced proinflammatory reaction and apoptosis in interferon-beta (IFN-β)-sensitized cells. The study provides evidence that pyrogallol alleviates excessive proinflammatory responses and abnormal cell death via HO-1 induction, suggesting it could be a potential agent for treating influenza.

Keywords

acute lung injury / heme oxygenase 1 (HO-1) / influenza A virus / pyrogallol / retinoic acid inducible gene I (RIG-I) / type I interferons

References

1	AD Iuliano, KM Roguski, HH Chang, et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet. 2018;391(10127):1285-1300.
2	EA Gorman, CM O'Kane, DF McAuley. Acute respiratory distress syndrome in adults: diagnosis, outcomes, long-term sequelae, and management. Lancet. 2022;400(10358):1157-1170.
3	X Jia, B Liu, L Bao, et al. Delayed oseltamivir plus sirolimus treatment attenuates H1N1 virus-induced severe lung injury correlated with repressed NLRP3 inflammasome activation and inflammatory cell infiltration. PLoS Pathog. 2018;14(11):e1007428.
4	BJ Zheng, KW Chan, YP Lin, et al. Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza a/H5N1 virus. Proc Natl Acad Sci USA. 2008;105(23):8091-8096.
5	MF Montenegro-Landívar, P Tapia-Quirós, X Vecino, et al. Polyphenols and their potential role to fight viral diseases: an overview. Sci Total Environ. 2021;801:149719.
6	HN Kim, JD Kim, SB Park, et al. Anti-inflammatory activity of the extracts from Rodgersia podophylla leaves through activation of Nrf2/HO-1 pathway, and inhibition of NF-κB and MAPKs pathway in mouse macrophage cells. Inflamm Res. 2020;69(2):233-244.
7	CJ Yang, CS Wang, JY Hung, et al. Pyrogallol induces G2-M arrest in human lung cancer cells and inhibits tumor growth in an animal model. Lung Cancer. 2009;66(2):162-168.
8	TH Tinh, T Nuidate, V Vuddhakul, et al. Antibacterial activity of pyrogallol, a polyphenol compound against vibrio parahaemolyticus isolated from the central region of thailand. Procedia Chem. 2016;18:162-168.
9	H Ahn, E Im, DY Lee, et al. Antitumor effect of pyrogallol via miR-134 mediated s phase arrest and inhibition of PI3K/AKT/Skp2/cMyc signaling in hepatocellular carcinoma. Int J Mol Sci. 2019;20(16):3985.
10	Y Zhang, S Yang, Z Qiu, et al. Pyrogallol enhances therapeutic effect of human umbilical cord mesenchymal stem cells against LPS-mediated inflammation and lung injury via activation of Nrf2/HO-1 signaling. Free Radic Biol Med. 2022;191:66-81.
11	B Zhou, L Wang, Z Ren, et al. Pyrogallol promotes growth arrest by activating the p53-mediated up-regulation of p21 and p62/SQSTM1-dependent degradation of β-catenin in nonsmall cell lung cancer cells. Environ Toxicol. 2023;39(4):2150-2165.
12	YH Han, SZ Kim, SH Kim, et al. Pyrogallol as a glutathione depletor induces apoptosis in HeLa cells. Int J Mol Med. 2008;21(6):721-730.
13	SW Kim, YW Han, ST Lee, et al. A superoxide anion generator, pyrogallol, inhibits the growth of HeLa cells via cell cycle arrest and apoptosis. Mol Carcinog. 2008;47(2):114-125.
14	K Furuno, T Akasako, N Sugihara. The contribution of the pyrogallol moiety to the superoxide radical scavenging activity of flavonoids. Biol Pharm Bull. 2002;25(1):19-23.
15	H Su, S Yao, W Zhao, et al. Identification of pyrogallol as a warhead in design of covalent inhibitors for the SARS-CoV-2 3CL protease. Nat Commun. 2021;12(1):3623.
16	Y Liu, D Olagnier, R Lin. Host and viral modulation of RIG-I-mediated antiviral immunity. Front Immunol. 2016;7:662.
17	L Zhao, X Zhang, Z Wu, et al. The downregulation of microRNA hsa-miR-340-5p in IAV-infected A549 cells suppresses viral replication by targeting RIG-I and OAS2. Mol Ther Nucleic Acids. 2019;14:509-519.
18	M Kandasamy, A Suryawanshi, S Tundup, et al. RIG-I signaling is critical for efficient polyfunctional T cell responses during influenza virus infection. PLoS Pathog. 2016;12(7):e1005754.
19	C Chiang, V Beljanski, K Yin, et al. Sequence-specific modifications enhance the broad-spectrum antiviral response activated by RIG-I agonists. J Virol. 2015;89(15):8011-8025.
20	Q Liu, YH Zhou, ZQ Yang. The cytokine storm of severe influenza and development of immunomodulatory therapy. Cell Mol Immunol. 2016;13(1):3-10.
21	W Wu, X Wang, W Zhang, et al. RIG-I signaling via MAVS is dispensable for survival in lethal influenza infection in vivo. Mediat Inflamm. 2018;2018:6808934.
22	KP Hui, SM Lee, CY Cheung, et al. H5N1 influenza virus-induced mediators upregulate RIG-I in uninfected cells by paracrine effects contributing to amplified cytokine cascades. J Infect Dis. 2011;204(12):1866-1878.
23	TH Mogensen. IRF and STAT transcription factors—from basic biology to roles in infection, protective immunity, and primary immunodeficiencies. Front Immunol. 2018;9:3047.
24	TM Desai, M Marin, CR Chin, et al. IFITM3 restricts influenza a virus entry by blocking the formation of fusion pores following virus-endosome hemifusion. PLoS Pathog. 2014;10(4):e1004048.
25	X Wang, ER Hinson, P Cresswell. The interferon-inducible protein viperin inhibits influenza virus release by perturbing lipid rafts. Cell Host Microbe. 2007;2(2):96-105.
26	S Davidson, S Crotta, TM McCabe, et al. Pathogenic potential of interferon αβ in acute influenza infection. Nat Commun. 2014;5:3864.
27	K H?gner, T Wolff, S Pleschka, et al. Macrophage-expressed IFN-β contributes to apoptotic alveolar epithelial cell injury in severe influenza virus pneumonia. PLoS Pathog. 2013;9(2):e1003188.
28	BX Zhou, J Li, XL Liang, et al. β-sitosterol ameliorates influenza A virus-induced proinflammatory response and acute lung injury in mice by disrupting the cross-talk between RIG-I and IFN/STAT signaling. Acta Pharmacol Sin. 2020;41(9):1178-1196.
29	X Liang, Y Huang, X Pan, et al. Erucic acid from Isatis indigotica Fort. suppresses influenza A virus replication and inflammation in vitro and in vivo through modulation of NF-κB and p38 MAPK pathway. J Pharm Anal. 2020;10(2):130-146.
30	HY Cho, W Gladwell, X Wang, et al. Nrf2-regulated PPARγ expression is critical to protection against acute lung injury in mice. Am J Respir Crit Care Med. 2010;182(2):170-182.
31	C Lee. Collaborative power of Nrf2 and PPARγ activators against metabolic and drug-Induced oxidative injury. Oxid Med Cell Longev. 2017;2017:1378175.
32	Y Gu, AC Hsu, Z Pang, et al. Role of the innate cytokine storm induced by the influenza A virus. Viral Immunol. 2019;32(6):244-251.
33	H Dong, Z Qiang, D Chai, et al. Nrf2 inhibits ferroptosis and protects against acute lung injury due to intestinal ischemia reperfusion via regulating SLC7A11 and HO-1. Aging (Albany N Y). 2020;12(13):12943-12959.
34	Q Wang, Y Ji, X Wang, et al. Isolation and molecular characterization of the 5'-upstream region of the human TRAIL gene. Biochem Biophys Res Commun. 2000;276(2):466-471.
35	LJ Jiang, NN Zhang, F Ding, et al. RA-inducible gene-I induction augments STAT1 activation to inhibit leukemia cell proliferation. Proc Natl Acad Sci USA USA. 2011;108(5):1897-1902.
36	BM Wynne, L Zou, V Linck, et al. Regulation of lung epithelial sodium channels by cytokines and chemokines. Front Immunol. 2017;8:766.
37	R Herrero, G Sanchez, JA Lorente. New insights into the mechanisms of pulmonary edema in acute lung injury. Ann Transl Med. 2018;6(2):32.
38	MJ Kesic, SO Simmons, R Bauer, et al. Nrf2 expression modifies influenza A entry and replication in nasal epithelial cells. Free Radical Biol Med. 2011;51(2):444-453.
39	B Zhou, L Wang, Y Liang, et al. Arctiin suppresses H9N2 avian influenza virus-mediated inflammation via activation of Nrf2/HO-1 signaling. BMC Complement Med Ther. 2021;21(1):289.
40	LE Fredenburgh, MA Perrella, SA Mitsialis. The role of heme oxygenase-1 in pulmonary disease. Am J Respir Cell Mol Biol. 2007;36(2):158-165.
41	JK Sarady-Andrews, F Liu, D Gallo, et al. Biliverdin administration protects against endotoxin-induced acute lung injury in rats. Am J Physiol Lung Cell Mol Physiol. 2005;289(6):L1131-1137.
42	R Channappanavar, AR Fehr, R Vijay, et al. Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice. Cell Host Microbe. 2016;19(2):181-193.
43	B Lee, KM Robinson, KJ McHugh, et al. Influenza-induced type I interferon enhances susceptibility to gram-negative and gram-positive bacterial pneumonia in mice. Am J Physiol Lung Cell Mol Physiol. 2015;309(2):L158-167.
44	A García-Sastre. Induction and evasion of type I interferon responses by influenza viruses. Virus Res. 2011;162(1-2):12-18.
45	TF Olonisakin, T Suber, S Gonzalez-Ferrer, et al. Stressed erythrophagocytosis induces immunosuppression during sepsis through heme-mediated STAT1 dysregulation. J Clin Invest. 2021;131(1).
46	CW Liu, HW Lin, DJ Yang, et al. Luteolin inhibits viral-induced inflammatory response in RAW264.7 cells via suppression of STAT1/3 dependent NF-κB and activation of HO-1. Free Radic Biol Med. 2016;95:180-189.
47	VL Capelozzi, ER Parra, M Ximenes, et al. Pathological and ultrastructural analysis of surgical lung biopsies in patients with swine-origin influenza type a/H1N1 and acute respiratory failure. Clinics (Sao Paulo). 2010;65(12):1229-1237.
48	WJ Wurzer, C Ehrhardt, S Pleschka, et al. NF-kappaB-dependent induction of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas/FasL is crucial for efficient influenza virus propagation. J Biol Chem. 2004;279(30):30931-30937.
49	D Morse, L Lin, AM Choi, et al. Heme oxygenase-1, a critical arbitrator of cell death pathways in lung injury and disease. Free Radic Biol Med. 2009;47(1):1-12.
50	X Zhang, P Shan, LE Otterbein, et al. Carbon monoxide inhibition of apoptosis during ischemia-reperfusion lung injury is dependent on the p38 mitogen-activated protein kinase pathway and involves caspase 3. J Biol Chem. 2003;278(2):1248-1258.
51	Y Zheng, Y Huang, Y Xu, et al. Ferroptosis, pyroptosis and necroptosis in acute respiratory distress syndrome. Cell Death Discov. 2023;9(1):91.
52	EA Choi, H Lei, DJ Maron, et al. Stat1-dependent induction of tumor necrosis factor-related apoptosis-inducing ligand and the cell-surface death signaling pathway by interferon beta in human cancer cells. Cancer Res. 2003;63(17):5299-5307.
53	EL Brincks, TA Kucaba, KL Legge, et al. Influenza-induced expression of functional tumor necrosis factor-related apoptosis-inducing ligand on human peripheral blood mononuclear cells. Hum Immunol. 2008;69(10):634-646.
54	M Matrosovich, T Matrosovich, W Garten, et al. New low-viscosity overlay medium for viral plaque assays. Virol J. 2006;3:63.
55	L Deng, W Min, S Guo, et al. Interference of pseudorabies virus infection on functions of porcine granulosa cells via apoptosis modulated by MAPK signaling pathways. Virol J. 2024;21(1):25.
56	JC Horvat, KW Beagley, MA Wade, et al. Neonatal chlamydial infection induces mixed T-cell responses that drive allergic airway disease. Am J Respir Crit Care Med. 2007;176(6):556-564.